期刊
ACTA PHARMACEUTICA SINICA B
卷 13, 期 5, 页码 2071-2085出版社
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2023.02.004
关键词
Universal CAR-T cells; Fcy receptor; CD16a; CD32a; CD64; Affinity; IgG1 antibody; CRS
There is an urgent need to develop universal CARs with improved flexible targeting and controllable activities. This study systematically investigated the impact of Fcy receptor (FcyR) affinity on CAR-T cells properties by constructing universal CARs using Fcy receptors with different affinities for IgG1 antibodies. The results demonstrated that redirecting and regulating the activities of universal CAR-T cells on tumor cells could be achieved through IgG1 antibodies, and only the FcyRCAR with an appropriate affinity can offer the optimal antitumor advantages of CAR-T cells.
Developing universal CARs with improved flexible targeting and controllable activities is urgently needed. While several studies have suggested the potential of CD16a in tandem with monoclonal antibodies to construct universal CAR-T cells, the weak affinity between them is one of the limiting factors for efficacy. Herein, we systematically investigated the impact of Fcy receptor (FcyR) affinity on CAR-T cells properties by constructing universal CARs using Fcy receptors with different affinities for IgG1 antibodies, namely CD16a, CD32a, and CD64. We demonstrated that the activities of these universal CAR-T cells on tumor cells could be redirected and regulated by IgG1 antibodies. In xenografted mice, 64CAR chimeric Jurkat cells with the highest affinity showed significant antitumor effects in combination with herceptin in the HER2 low expression U251 MG model. However, in the CD20 high expression Raji model, 64CAR caused excessive activation of CAR-T cells, which resulted in cytokine release syndrome (CRS) and the decline of antitumor activity, and 32CAR with a moderate affinity brought the best efficacy. Our work extended the knowledge about FcyR-based universal CAR-T cells and suggested that only the FcyRCAR with an appropriate affinity can offer the optimal antitumor advantages of CAR-T cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据